Insider · CIK 0002007795
Amit Etkin
ceopresidentofficerdirector
Files at ANRO (Alto Neuroscience, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +34,620 | - | - | 34,620 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -34,620 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +247,290 | - | - | 247,290 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -247,290 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +223,000 | - | - | 223,000 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -223,000 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +215,000 | - | - | 215,000 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -215,000 | - | - | 0 | Jul 8, 2025 |
| Feb 5, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.